In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
BioSante licenses vaccine technology to Corixa
BioSante Pharmaceuticals Announces Positive Results of CAP Adjuvant Study in CDC Collaboration
Medi-Ject and Biosante announce vaccine collaboration results
BioSante signs option agreement with Antex
BioSante and ID Biomedical sign option license agreement
BioSante awarded Japanese patent
Protherics acquires novel vaccine adjuvant and prepares for phase 2 study of its angiotensin vaccine
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
BioSante and U.S. Army co-developing ricin vaccine
BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
